Effect of sofosbuvir-based DAAs on changes in lower-density lipoprotein in HCV patients: a systematic review and meta-analysis

Effect of sofosbuvir-based DAAs on changes in lower-density lipoprotein in HCV patients: a systematic review and meta-analysis

Abstract Background Previous studies reported worsened lipid profiles in patients infected with hepatitis C virus (HCV) during direct-acting antivirals (DAAs) treatment. This study aimed to investigate the effect of sofosbuvir (SOF)-based DAAs on changes in low-density lipoprotein (LDL) in HCV patie...

Full description

Bibliographic Details
Main Authors: Ying-Wen Wang, Wei-Ping Lee, Yi-Hsiang Huang, Ming-Chih Hou, Keng-Hsin Lan
Format: Article
Language:English
Published: BMC 2021-09-01
Series:BMC Infectious Diseases
Subjects:
Direct-acting antivirals
Hepatitis C virus
Lipids
Low-density lipoprotein
Sofosbuvir
Online Access:https://doi.org/10.1186/s12879-021-06657-9

Internet

https://doi.org/10.1186/s12879-021-06657-9

Similar Items